Fed. Circ. OKs PTAB's Trim Of Luitpold Iron Patents
Law360 (April 12, 2018, 7:34 PM EDT) -- The Federal Circuit on Thursday affirmed a set of Patent Trial and Appeal Board decisions trimming two of Luitpold Pharmaceuticals Inc.'s iron patents, shooting down the Daiichi Sankyo Co. company's push for relief.
In two rulings from December 2016 and January 2017, the board trimmed a total of 25 claims from U.S. Patent Numbers 7,754,702 and 8,431,549, both of which cover administering stable, high doses of iron. A three-judge panel cleared that decision without expanding on its reasoning.
Specifically, the PTAB invalidated 16 of the '702 patent's 57 claims and 9 of the '549 patent's 23 claims. The board also upheld...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!